DekaBank Deutsche Girozentrale - UNIQURE NV ownership

UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 97 filers reported holding UNIQURE NV in Q2 2018. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of UNIQURE NV
ValueSharesWeighting
Q1 2023$767
-12.8%
39,4000.0%0.00%0.0%
Q4 2022$880
-99.9%
39,4000.0%0.00%0.0%
Q3 2022$694,000
-2.8%
39,4000.0%0.00%0.0%
Q2 2022$714,000
+1.4%
39,4000.0%0.00%0.0%
Q1 2022$704,000
-18.4%
39,400
-7.1%
0.00%0.0%
Q4 2021$863,000
-33.0%
42,400
+2.7%
0.00%
-50.0%
Q3 2021$1,288,000
+1.7%
41,3000.0%0.00%0.0%
Q2 2021$1,266,000
-6.8%
41,3000.0%0.00%
-20.0%
Q1 2021$1,359,000
+130.7%
41,300
+153.4%
0.01%
+150.0%
Q4 2020$589,000
-3.0%
16,300
-4.7%
0.00%
-33.3%
Q3 2020$607,000
+52.1%
17,100
+69.3%
0.00%
+50.0%
Q3 2019$399,000
-73.8%
10,100
-50.0%
0.00%
-75.0%
Q2 2019$1,520,000
+192.3%
20,200
+64.2%
0.01%
+166.7%
Q1 2019$520,000
+99.2%
12,300
+21.8%
0.00%
+50.0%
Q4 2018$261,000
-49.8%
10,100
-17.9%
0.00%
-33.3%
Q3 2018$520,000
+7.0%
12,300
-2.4%
0.00%0.0%
Q2 2018$486,000
+62.5%
12,6000.0%0.00%
+50.0%
Q1 2018$299,000
+112.1%
12,600
+5.0%
0.00%0.0%
Q1 2016$141,00012,0000.00%
Other shareholders
UNIQURE NV shareholders Q2 2018
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 841,471$15,786,0005.69%
Nantahala Capital Management 2,901,929$54,440,0003.52%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 544,500$10,209,0003.27%
683 Capital Management, LLC 1,373,600$25,768,0001.99%
PFM Health Sciences, LP 2,393,311$44,899,0001.62%
Integral Health Asset Management, LLC 433,000$8,123,0001.58%
Privium Fund Management B.V. 238,998$4,283,0001.56%
Nantahala Capital Management 1,000,000$18,760,0001.21%
Henry James International Management Inc. 89,469$1,678,0000.94%
Altium Capital Management LP 105,000$1,970,0000.72%
View complete list of UNIQURE NV shareholders